Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment of transthyretin (TTR) amyloid cardiomyopathy with an antisense oligonucleotide inhibitor of TTR synthesis ; volume:10 ; number:1 ; day:2 ; month:11 ; year:2015 ; pages:1 ; date:12.2015
Orphanet journal of rare diseases ; 10, Heft 1 (2.11.2015), 1, 12.2015
- Urheber
-
Benson, Merrill D.
Ackermann, Elizabeth J.
Monia, Brett P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-10-S1-P7
- URN
-
urn:nbn:de:101:1-2020100521582378161213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Benson, Merrill D.
- Ackermann, Elizabeth J.
- Monia, Brett P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Annual Cardiovascular-Related Hospitalization Days Avoided with Tafamidis in Patients with Transthyretin Amyloid Cardiomyopathy
Diagnosis of Transthyretin Amyloid Cardiomyopathy
Transthyretin Amyloid Cardiomyopathy in a Young Female
Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges
Molecular mechanisms and emerging therapies in wild-type transthyretin amyloid cardiomyopathy
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness
Antisense oligonucleotide therapeutic approach for Timothy syndrome
Nonviral delivery systems for antisense oligonucleotide therapeutics
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy